Print This Page Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More R&D Hexion Rejects Huntsman Shareholder Plan to Salvage BuyoutMonsanto, Evogene Team Up for Stress-Resistant GenesCodexis, Arch Pharmalabs Expand Pharma Manufacturing DealIndia Approves Policy to Encourage Urea InvestmentsMitsui Develops Novel Catalysts Related Stories J&J Expands R&D in IndiaPfizer Outsources More to AsiaEvonik Boosts R&D Center in IndiaJubilant, Amgen Enter Drug Discovery DealRanbaxy Buys Biopharma Stake

EnviroTech :: R&D

September 12, 2007

Nicholas Piramal to Spin Off R&D Unit

Deepti Ramesh

Pharmaceutical company Nicholas Piramal India Ltd. (NPIL; Mumbai) says it plans to demerge its R&D unit, creating a separate, independent company focused on developing novel drugs, otherwise known as new chemical entities (NCE). The demerger will be in...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers